Official data from INPI

122022015686

Em AnáliseUtility ModelPCT · US2015019535

Talk to an expert

Application data

Number

122022015686

Type

Utility Model

Filing

03/09/2015

Publication

PCT

US2015019535

View on INPI

Progress at the INPI

Under appeal

Filing03/09/15
Publication
Examination
Allowance
Grant
In force

The application is under appeal: the INPI has yet to review the decision.

Latest action published by the INPI: 11/29/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BIOCRYST PHARMACEUTICALS, INC.

See this company's full portfolio

Inventors

No inventors listed.

Technical data

IPC Classification

No IPC classification.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Petição de recurso

#12.2

Recurso: 870220108365 - 23/11/2022

11/29/2022

RPI 2708

Indeferimento

#9.2

09/27/2022

RPI 2699

Notificação de pedido dividido

#2.4

09/13/2022

RPI 2697

Requerimento de pedido de patente

#2.10

Número de Protocolo '870220070669' em 08/08/2022 18:10 (WB)

08/16/2022

RPI 2693

From the same holder

112026009893 112026003945 INIBIDORES DE PROTEÍNA DE FUSÃO DE KLK5 INIBIDORES DE ALK2 CINASE CONTENDO IMIDAZOL, SEUS USOS, COMPOSIÇÃO FARMACÊUTICA, E KIT INIBIDORES HETEROAROMÁTICOS BICÍCLICOS DE KLK5 AMINAS DE PIRROLOPIRIMIDINA COMO INIBIDORES DE COMPLEMENTO INIBIDORES ORAIS DO FATOR D DO COMPLEMENTO, COMPOSIÇÃO FARMACÊUTICA, USOS DOS MESMOS E KIT INIBIDORES ORAIS DO FATOR D DO COMPLEMENTO, COMPOSIÇÃO FARMACÊUTICA, USOS DESTES E KIT

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.